Clinical trial Recruiting at 1 site Interventional Ages 18 to 24 Women only

Video-assisted laughter yoga for menstrual pain in university students

Official title: Investigation of The Effect of Video-Assisted Laughter Yoga on Pain and Menstrual Symptoms in Primary Dysmenorrhea

Run by Ataturk University · NCT07514546 · Data updated 2026-11-12

This project will test whether video-assisted laughter yoga can reduce menstrual pain and other period symptoms in university students aged 18–24 with primary dysmenorrhea.

More Laughter Yoga trials

Quick facts

Study typeInterventional
Ages18 Years to 24 Years
SexWomen only
Enrollment68 (estimated)
SponsorAtaturk University
Academic / other
Locations1 site (Konya, Karatay)
StatusRecruiting
StartedDecember 30, 2024
Main results expectedNovember 3, 2025
Study endsApril 22, 2026
Registry record updatedApril 7, 2026
Trial IDNCT07514546 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are female students aged 18–24 at the Faculty of Health Sciences with regular menstrual cycles and primary dysmenorrhea scoring ≥45 mm on the VAS who can attend the scheduled sessions.

Probably not a fit

Those with secondary causes of dysmenorrhea, current use of oral contraceptives, compromised abdominal tissue, or chronic/mental illnesses are excluded and may not receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will recruit female students aged 18–24 from the Faculty of Health Sciences at KTO Karatay University and randomly assign eligible participants to an experimental or control group. Pre-test measures including a Visual Analog Scale for pain and a menstrual symptoms questionnaire will be collected face-to-face, then the experimental group will receive 24 video-assisted laughter yoga sessions delivered in person, with post-test assessments after the last session. The sample size was calculated to require at least 68 participants to achieve 90% power with an effect size of d=0.8. Exclusion criteria include secondary dysmenorrhea, current oral contraceptive use, compromised abdominal tissue integrity, and any chronic or mental illness.

Why it matters

Potential benefit: If effective, this could offer a low-cost, non-drug way to reduce period pain and improve menstrual symptoms for young women.

How similar studies have gone: Small prior studies of laughter therapy and related mind–body interventions have reported reductions in pain and stress, but rigorous evidence specifically for video-assisted laughter yoga in primary dysmenorrhea is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Students with regular menstrual periods (lasting 3-8 days, with a menstrual cycle range of 21-35 days)
* Students with dysmenorrhea pain intensity of 45 mm or more according to the Visual Analog Scale (VAS).

Exclusion Criteria:

* Students diagnosed with secondary dysmenorrhea (endometriosis, ovarian cyst/tumor, pelvic infectious disease, myoma, uterine polyps, uterine adhesions, infection, etc.),
* those using oral contraceptives,
* those with compromised tissue integrity in the abdominal area,
* those with any chronic or mental illness.

Where it's running

  • KTO Karatay Üniversitesi
    Konya, Karatay, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.